Search This Blog

Thursday, August 1, 2019

Adaptimmune EPS beats by $0.29, misses on revenue

Adaptimmune (NASDAQ:ADAP): Q2 GAAP EPS of -$0.07 beats by $0.29.
Revenue of $0.2M (-97.8% Y/Y) misses by $1.72M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)